ダウンロード数: 313
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
41_227.pdf | 4.65 MB | Adobe PDF | 見る/開く |
タイトル: | 膀胱癌肺転移巣に対してMethotrexate,Epirubicin,Cisplatinの多剤併用化学療法が著効を示した1例 |
その他のタイトル: | Complete response of lung metastasis from bladder cancer by combination chemotherapy with methotrexate, epirubicin and cisplatin: a case report |
著者: | 大内, 秀紀 野口, 純男 増田, 光伸 執印, 太郎 窪田, 吉信 穂坂, 正彦 |
著者名の別形: | Oouchi, Hideki Noguchi, Sumio Masuda, Mitsunobu Shuin, Taro Kubota, Yoshinobu Hosaka, Masahiko |
キーワード: | Lung metastasis Bladder cancer Combination chemotherapy |
発行日: | Mar-1995 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 41 |
号: | 3 |
開始ページ: | 227 |
終了ページ: | 230 |
抄録: | We report a case of lung metastasis from bladder cancer effectively responding to a combination chemotherapy using methotrexate, epirubicin and cisplatin (MEC therapy). A 78-year-old man with high grade bladder cancer underwent total cystectomy on June 5, 1991. He was pointed out to have an abnormal shadow on the plain chest X-ray on August 14, 1992. Computed tomography demonstrated multiple lung metastasis. MEC combination chemotherapy was applied for this case. After 3 courses of MEC therapy, computed tomography showed marked regression of tumor. He has been alive for 12 months with no evidence of disease after chemotherapy. Toxicity of MEC therapy were moderate myelosuppression and mild anorexia and alopecia. These toxicity was adequately tolerable by the 78-year-old patient. This case suggests that MEC therapy is effective against advanced bladder cancer. |
URI: | http://hdl.handle.net/2433/115460 |
PubMed ID: | 7741078 |
出現コレクション: | Vol.41 No.3 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。